#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14694	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2078	700.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1395	1395	C	817	C	764	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26266	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3528	742.5	0	.	n	.	0	A20C	SNP	20	20	A	333	333	C	461	C,A	437,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26266	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3528	742.5	0	.	n	.	0	T695C	SNP	695	695	T	1008	1008	C	814	C	767	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26266	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3528	742.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	1951	1951	G	841	G	802	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26266	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3528	742.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2284	2284	C	871	C	791	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26266	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3528	742.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2358	2358	A	878	A	832	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26266	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3528	742.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2910	2910	C	867	C	809	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26266	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3528	742.5	0	HET	.	.	.	A412G	.	412	412	A	725	725	A	810	A,G	538,191	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1868	folP	855	855	100.0	folP.l15.c4.ctg.1	1695	109.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1052	1054	AGC	205;203;199	A;G;C	193;193;189	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5288	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3395	155.5	1	SNP	p	S91F	1	.	.	271	273	TTC	587	589	TTC	197;197;196	T;T;C	184;181;181	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5288	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3395	155.5	1	SNP	p	G95N	0	.	.	283	285	GGC	599	601	GGC	189;187;184	G;G;C	175;173;171	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5288	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3395	155.5	1	SNP	p	D95G	1	.	.	283	285	GGC	599	601	GGC	189;187;184	G;G;C	175;173;171	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1494	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1194	124.0	0	.	p	.	0	F184L	NONSYN	550	552	TTC	825	827	TTG	178;178;183	T;T;G	162;162;168	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1494	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1194	124.0	1	SNP	p	G45D	0	.	.	133	135	GGC	408	410	GGC	192;190;190	G;G;C	176;177;179	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	782	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	870	88.7	0	.	n	.	0	A197.	DEL	197	197	A	495	495	A	199	A	185	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5040	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3214	156.5	1	SNP	p	D86N	0	.	.	256	258	GAC	731	733	GAC	201;200;202	G;A;C	192;185;188	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5040	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3214	156.5	1	SNP	p	R87W	0	.	.	259	261	CGT	734	736	CGT	202;203;198	C;G;T	188;191;186	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5040	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3214	156.5	1	SNP	p	S87R	1	.	.	259	261	CGT	734	736	CGT	202;203;198	C;G;T	188;191;186	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5040	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3214	156.5	1	SNP	p	R87I	0	.	.	259	261	CGT	734	736	CGT	202;203;198	C;G;T	188;191;186	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5040	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3214	156.5	1	SNP	p	S88P	0	.	.	262	264	TCC	737	739	TCC	197;199;202	T;C;C	186;186;190	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3980	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2531	156.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1498	1500	GGC	206;201;197	G;G;C	186;184;175	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1147	1149	GCA	184;183;183	G;C;A	170;166;168	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1150	1152	ATC	187;190;192	A;T;C,T	172;172;173,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1162	1164	GTG	194;190;188	G,C;T;G	176,1;172;173	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1162	1164	GTG	194;190;188	G,C;T;G	176,1;172;173	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1666	1668	ACC	215;216;214	A;C;C	195;197;194	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1720	1722	GCG	188;188;187	G;C,G;G	167;149,1;153	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1720	1722	GCG	188;188;187	G;C,G;G	167;149,1;153	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1843	1845	AGC	200;199;197	A;G;C	182;186;185	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1852	1854	GGC	189;185;182	G;G;C	176;172;168	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2255	168.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1870	1872	CCG	154;155;154	C,G;C,G;G	110,4;113,1;113	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5196	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3019	171.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1579	1581	CTG	184;182;181	C,T;T;G	155,1;152;152	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2166	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1827	117.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	586	586	C	157	C	141	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2728	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1644	164.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	564	566	GAA	236;234;234	G;A;A	218;217;219	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2728	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1644	164.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	975	977	TCA	239;239;242	T;C;A	222;221;225	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2728	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1644	164.6	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1104	1106	GTC	241;241;240	G;T;C	229;226;228	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2728	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1644	164.6	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1116	1118	TCT	243;242;241	T;C;T,C,A	232;230;227,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2728	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1644	164.6	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1434	1436	GCA	197;197;197	G;C;A	188;187;187	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2728	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1644	164.6	1	SNP	p	G120K	1	.	.	358	360	AAG	810	812	AAG	227;228;233	A;A;G,C	215;216;217,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2728	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1644	164.6	1	SNP	p	D121N	0	.	.	361	363	GAC	813	815	GAC	236;241;239	G,C;A;C	218,1;221;223	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2728	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1644	164.6	1	SNP	p	A121D	1	.	.	361	363	GAC	813	815	GAC	236;241;239	G,C;A;C	218,1;221;223	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10368	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4733	218.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1080	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1219	88.3	1	SNP	p	V57M	1	.	.	169	171	ATG	552	554	ATG	233;233;230	A;T;G	218;219;218	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
